1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Brazil

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Brazil
BRAZIL 1
HEALTHCARE SYSTEM1
Facts and Figures1
Market Indicators2
Provision and Funding4
Healthcare System4
Decentralisation5
Healthcare Funding5
Healthcare Services5
Private Health Insurance6
PRICING 7
Prescription Drugs7
Pricing Procedure7
Drug Categories8
Application 9
Pricing Methodology10
Timelines11
Appeals11
Local Manufacturing Agreements 11
Generic Drugs12
Generics12
Similares13
Hospital Drugs13
Mandatory Discount13
Other Discounts14
Tendering14
OTC Drugs15
REIMBURSEMENT15
Admission to Reimbursement15
SUS Reimbursement Coverage16
RENAME17
Controversy 18
Popular Pharmacy Programme 19
Positive, Negative and Neutral Lists20
Private Health Plans 20
Reimbursement Categories21
Reimbursement Prices21
Hospital Reimbursement21
Formularies21
Funding22
Changes in Reimbursement Status23
Changes in Reimbursement Prices24
Annual Price Adjustment Limits 24
CAP Discounts25
PHARMACOECONOMICS 25
Pharmacoeconomic Requirements25
Pricing 25
Reimbursement 25
PRICE BUILD UP27
Wholesalers27
Margins27
Background28
Retail Pharmacies28
Margins28
Background29
Regulations29
Dispensing Doctors30
Sales Tax30
Recent Sales Tax Changes31
Recent Reform Proposals32
COST CONTAINMENT32
Industry Paybacks32
Promotional Costs32
Patient Co-payments33
Prescribing Controls33
National Therapeutic Formulary33
Protocols and Guidelines34
INN Prescribing 34
Hospital Sector34
Generics34
New Rules for Similares/Branded Copies35
Substitution35
Rx-to-OTC Switches36
OTC Sales36
Parallel Trade36
Counterfeit Trade36
FUTURE DEVELOPMENTS37
Outlook37
Healthcare Budget37
Popular Pharmacy Programme38
Sales Tax38
Orphan Drugs38
Medical Lawsuits39
NAMES and ADDRESSES40

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the Netherlands

  • January 2017
    5 pages
  • Therapy  

  • Netherlands  

View report >

Global Therapy Market

  • January 2017
    32 pages
  • Therapy  

    Targeted Therap...  

    Monoclonal Anti...  

  • World  

View report >

Anti-Infective Market in India

  • January 2017
    4 pages
  • Anti-Infective  

    Blood Disease  

  • India  

    United States  

View report >

Therapy Market

1 day ago

Related Market Segments :

Therapy
Anti-Infective
Pharmaceutical
Hospital

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.